©The Author(s) 2025.
World J Gastrointest Surg. Sep 27, 2025; 17(9): 109980
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.109980
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.109980
Figure 6 Variation of immune system.
aP < 0.05 compared with baseline values in low-dose group; cP < 0.05 compared with baseline values in high-dose group; dP < 0.05 compared among three group in the same visit. A: CD4+ T cell; B: CD8+ cell; C: Natural killer cell; D: Interleukin-8. NK cell: Natural killer cell; IL-8: Interleukin-8.
- Citation: Qin X, Chen J, Zhang HN, Du L, Ma Y, Li Y, Lu Y, Wang YT, Wu LF, Yu ZH, Hu MJ, Li LJ, Liao B, Li Z, Yang ZY, Li K, Yuan YF. Treatment of human umbilical cord-derived mesenchymal stem cells for hepatitis B virus-associated decompensated liver cirrhosis: A clinical trial. World J Gastrointest Surg 2025; 17(9): 109980
- URL: https://www.wjgnet.com/1948-9366/full/v17/i9/109980.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i9.109980